gastric-cancer

Documents about gastric-cancer

• EsophaCap for the Detection of Early Esophageal Carcinoma#481686ClinicalTrials.gov
• A Pilot Study of the Effect of High Protein Supplement and Exercise Therapy on Preservation of Skeletal Muscle Mass and Quality of Life in Patients With Gastric Cancer and Pancreatic Cancer Treated With Chemotherapy#865304ClinicalTrials.gov
• Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer#253053ClinicalTrials.gov
• Comparison of Short Term Outcomes Between Totally Laparoscopic and Laparoscopy-Assisted Distal Gastrectomy With Billroth-II Reconstruction and D2 Lymphadenectomy for Locally Advanced Gastric Cancer#865777ClinicalTrials.gov
• Anthocyanin-Rich Extracts of Calafate (Berberis microphylla G. Forst.) Fruits Decrease In Vitro Viability and Migration of Human Gastric and Gallbladder Cancer Cell Lines#948377Repositorio de Universidad Autónoma de Chile.
• Docetaxel and S1 (DS) Versus S1 and Cisplatin (SP) in Curatively Resected Stage IIIB/IV Gastric Cancer#813695ClinicalTrials.gov
• Fundic Gland Polyps and Proton Pump Inhibitor (PPI) Drugs#889675ClinicalTrials.gov
• A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis#857689ClinicalTrials.gov
• Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer#859534ClinicalTrials.gov
• The Long-term Effect of D4 Lymphadenectomy for Gastric Cancer#874329ClinicalTrials.gov
• The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer#890216ClinicalTrials.gov
• Dealing with the gray zones in the management of gastric cancer: the consensus statement of the İstanbul Group#955462Koc University Digital Collections
• Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric Adenocarcinoma#850494ClinicalTrials.gov
• Response Prediction of Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal Cancer#847478ClinicalTrials.gov
• A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC)#899323ClinicalTrials.gov
• Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates#994903ClinicalTrials.gov
• INSPIRE: a Multi-Cancer Early Detection Study#854463ClinicalTrials.gov
• A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2#839127ClinicalTrials.gov
• Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)#217045ClinicalTrials.gov
• Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers#837571ClinicalTrials.gov
• Nutrition Intervention Trials in Linxian Follow-up Study#909438ClinicalTrials.gov
• Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer#858097ClinicalTrials.gov
• First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma#893739ClinicalTrials.gov
• Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer#994084ClinicalTrials.gov
• Short-term Outcomes of SILS+1 Versus CLS for Distal Gastric Cancer#803178ClinicalTrials.gov
• Clinical Trial for Laparoscopic D2 Gastrectomy#869009ClinicalTrials.gov
• Clinical Trial of Chemosensitivity Test#1007987ClinicalTrials.gov
• Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation#852261ClinicalTrials.gov
• A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer#805261ClinicalTrials.gov
• A Clinical Study of Iparomlimab and Tuvonralimab Combined With SOX Following Heterogeneous Radiotherapy as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Gastric or Gastroesophageal Junction Adenocarcinoma#152407ClinicalTrials.gov
• Implementation of a Patient Blood Management Program in Gastric Cancer Surgery#831224ClinicalTrials.gov
• Effect and Safety of Huaier Granule Versus SOX Regimen in Gastric Cancer Patients#843819ClinicalTrials.gov
• Compare Adjuvant Chemotherapy of Docetaxel/Capecitabine/Oxliplatin Versus Capecitabine/Oxaliplatin in Advanced Gastric Cancer at Stage IIIb and IV(KCSG ST15-08): TRIUMPH#865136ClinicalTrials.gov
• Influence of Positive Margins on Tumour Recurrence and Overall Survival After Gastrectomy for Gastric Cancer#873434ClinicalTrials.gov
• Effect of Acupuncture for QoL in Gastric Cancer Patients Undergoing Adjuvant Chemotherapy: a Pilot Study#887488ClinicalTrials.gov
• Objective Sleep Characteristics and Neoadjuvant Immunotherapy Response in Gastric/GEJ Cancer#363594ClinicalTrials.gov
• Paracetamol Absorption Technique as a Method for Measuring Gastric Tube Outlet#805630ClinicalTrials.gov
• Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma#979090ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer#143661ClinicalTrials.gov
• Irinotecan in Treating Patients With Advanced Cancer of the Stomach#880065ClinicalTrials.gov
• Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum#890593ClinicalTrials.gov
• Vactosertib and Durvalumab in Gastric Cancer#806998ClinicalTrials.gov
• Learning Curve and Optimization of Robotic Gastrectomy#832776ClinicalTrials.gov
• LDRT Sequential NIPS Immunochemotherapy for Peritoneal Metastasis of Gastric and Colorectal Cancer#234427ClinicalTrials.gov
• A Phase 1 Study of LCAR-C182A Cells in the Treatment of Advanced Gastric Cancer and Pancreatic Ductal Adenocarcinoma#828718ClinicalTrials.gov
• DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy#862849ClinicalTrials.gov
• A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.#252979ClinicalTrials.gov
• Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer#390931ClinicalTrials.gov
• A Predictive Model Based on Narrow Band Imaging for Early Gastric Cancerous Lesions#803396ClinicalTrials.gov
• Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma.#808106ClinicalTrials.gov